Adenocarcinoma grows in the tissue of the prostate gland, but other types of cancer can also start in the prostate or spread ...

Survival rates for lung cancer and other types of cancer are usually given as a five-year relative survival rate, which is ...

Esophageal squamous cell carcinoma accounts for approximately 90% of all esophageal cancer cases. Projections estimate that ...

Lung cancer is the leading cause of cancer deaths among both men and women. Small-cell lung cancer (SCLC ... With SCLC, the 5-year survival rate is about 7%. Without treatment, survival is ...

Esophageal cancer, particularly esophageal squamous cell carcinoma (ESCC), is one of the most prevalent digestive ...

In a small study in a community oncology practice, more than 60% of patients with advanced squamous cell skin cancer treated ...

Head and neck squamous cell carcinomas responded better to a combination of two immunotherapies than to one immunotherapy ...

Understanding the symptoms, causes, and risk factors of esophageal cancer is important for early detection and prevention.

The FDA approved Tevimbra with chemotherapy for adults with unresectable or metastatic esophageal squamous cell carcinoma ...

China NMPA approves Akeso's penpulimab for first-line treatment of nasopharyngeal cancer: Hong Kong Tuesday, March 18, 2025, 17:00 Hrs [IST] Akeso Inc., a biopharmaceutical compan ...